Skip to main content


The global Companion Diagnostics Market is forecasted to reach USD 9.72 Billion by 2027, according to a new report by Emergen Research. It enables the recognition of the possibility of an individual benefiting from a medicine or having adverse effects. It assists in assessing the patient reaction to a procedure so that medication may be modified to improve health and effectiveness.